CompanyDrug

Tonghua Golden-Horse’s Octohydroaminoacridine Succinate Meets Phase III Endpoints in Alzheimer’s Disease

Policy / Regulatory

China’s NHC Expands Rare Disease List, Includes 21 Cancer Types

CompanyDrug

AIM Vaccine’s Serum-Free Rabies Vaccine Completes Phase III Safety Observation

CompanyDrug

Jiangsu Yahong’s Cevira Meets Primary Endpoint in Phase III Cervical HSIL Study

CompanyDrug

Hybio Pharmaceutical Gets NMPA Approval for COVID-19 Nasal Spray HY3000

CompanyDrug

GSK’s Ojjaara Approved by FDA for Anemic Myelofibrosis Patients

CompanyDrug

BeiGene Regains Full Rights to Tislelizumab After Terminating Novartis Deal

Company

Kinnate Biopharma Announces Restructuring and Job Cuts Amid Financial Pressures

CompanyDrug

Jiangsu Hengrui Pharmaceuticals Wins NMPA Approval for Two Novel Drug Candidates

CompanyDrug

Pfizer’s Cibinqo and Everest Medicines’ Cefepime-Taniborbactam Selected for Priority Reviews by CDE

CompanyDrug

EMA’s CHMP Supports Gilead’s Veklury for COVID-19 Patients with Hepatic Impairment

CompanyDeals

Eli Lilly Partners with Boundless Bio to Develop CHK1 Inhibitor for Solid Tumors